Clinical trial
Broad Effectiveness: Study With Aripiprazole
NCT00036361 · Otsuka Pharmaceutical Development & Commercialization, Inc., Industry · Completed
Key facts
| NCT number | NCT00036361 |
|---|---|
| Title | Broad Effectiveness: Study With Aripiprazole |
| Official title | Broad Effectiveness: Study With Aripiprazole |
| Lead sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc., Industry |
| Collaborators | Otsuka America Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 444 |
| Start date | Jul 1, 2002 |
| Primary completion | Jan 1, 2003 |
| Completion | Jan 1, 2003 |
| First posted | May 10, 2002 |
| Last update posted | Nov 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: